The potential role of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) single‐tablet regimen in the expanding spectrum of fixed‐dose combination therapy for HIV-Reference-Cited by-同舟云学术

The potential role of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) single‐tablet regimen in the expanding spectrum of fixed‐dose combination therapy for HIV

Published:2020-02-04 Issue:S1 Volume:21 Page:3-16
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Stellbrink H‐J¹,Lazzarin A²,Woolley I³^ORCID,Llibre JM⁴

Affiliation:

1. ICH Study Center Hamburg Germany

2. San Raffaele Scientific Institute Milan Italy

3. Monash Medical Centre Monash University Melbourne Vic Australia

4. University Hospital Germans Trias i Pujol and the “Fight AIDS” Foundation Badalona Spain

Funder

Gilead Sciences

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hiv.12833

Reference95 articles.

1. Improved life expectancy of people living with HIV: who is left behind?

2. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies

3. Effectiveness of antiretroviral therapy in the single-tablet regimen era

4. Single-tablet regimens in HIV: does it really make a difference?

5. Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between Prices of Fixed-dose and Free-equivalent Combination: A Survey of Medicines in China's National Reimbursement Drug List;2024-08-29

2. Biktarvy for the treatment of HIV infection: Progress and prospects;Biochemical Pharmacology;2023-11

3. Current drugs for HIV-1: from challenges to potential in HIV/AIDS;Frontiers in Pharmacology;2023-10-26

4. Projected Benefits of Long-Acting Antiretroviral Therapy in Nonsuppressed People With Human Immunodeficiency Virus Experiencing Adherence Barriers;Open Forum Infectious Diseases;2023-07-22

5. Antiretroviral drugs efavirenz, dolutegravir and bictegravir dysregulate blood-brain barrier integrity and function;Frontiers in Pharmacology;2023-03-08